Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Recombinant Protein estimated was at US$ 975.77 million in the year 2022, is projected to reach a revised size of US$ 2,320.21 million by 2029, growing at a CAGR of 13.02% during the forecast period 2023-2029.
North American market for Recombinant Protein was valued at $ 334.79 million in 2022 and will reach $ 736.53 million by 2029, at a CAGR of 11.75% during the forecast period of 2023 through 2029.
Asia-Pacific market for Recombinant Protein was valued at $ 362.89 million in 2022 and will reach $ 1,010.82 million by 2029, at a CAGR of 15.52% during the forecast period of 2023 through 2029.
Europe market for Recombinant Protein was valued at $ 240.37 million in 2022 and will reach $ 508.09 million by 2029, at a CAGR of 11.15% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein.
The Recombinant Protein market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Recombinant Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Recombinant Protein segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
- Bio-Techne Corporation
- Abcam PLC
- Merck KGaA
- Miltenyi Biotec
- Thermo Fisher Scientific
- ACROBiosystems
- Sino Biological
- Cytiva
- Eurogentec
- GenScript Biotech Corporation
- Reprocell
- BPS Bioscience
- Abnova Corporation
- ProSpec Tany TechnoGene
- Ajinomoto
Segment by Type
- Hormones
- Growth Factors
- Cytokines
- Plasma Protein Factor
- Recombinant Metabolic Enzymes
- Immune Checkpoint Regulators
- Others
Segment by Application
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
By Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Middle East & Africa
- GCC Countries
- South Africa
- Turkey
Core Chapters
- Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2022, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
- Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter Four: Detailed analysis of Recombinant Protein companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
- Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
- Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
- Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
- Chapter Twelve: Research Finding/Conclusion
Table of Contents
1 Market Overview of Recombinant Protein
- 1.1 Recombinant Protein Market Overview
- 1.1.1 Recombinant Protein Product Scope
- 1.1.2 Recombinant Protein Market Status and Outlook
- 1.2 Global Recombinant Protein Market Size Overview by Region 2018 VS 2022 VS 2029
- 1.3 Global Recombinant Protein Market Size by Region (2018-2029)
- 1.4 Global Recombinant Protein Historic Market Size by Region (2018-2023)
- 1.5 Global Recombinant Protein Market Size Forecast by Region (2024-2029)
- 1.6 Key Regions Recombinant Protein Market Size (2018-2029)
- 1.6.1 North America Recombinant Protein Market Size (2018-2029)
- 1.6.2 Europe Recombinant Protein Market Size (2018-2029)
- 1.6.3 Asia-Pacific Recombinant Protein Market Size (2018-2029)
- 1.6.4 South America Recombinant Protein Market Size (2018-2029)
- 1.6.5 Middle East & Africa Recombinant Protein Market Size (2018-2029)
2 Recombinant Protein Market Overview by Type
- 2.1 Global Recombinant Protein Market Size by Type: 2018 VS 2022 VS 2029
- 2.2 Global Recombinant Protein Historic Market Size by Type (2018-2023)
- 2.3 Global Recombinant Protein Forecasted Market Size by Type (2024-2029)
- 2.4 Hormones
- 2.5 Growth Factors
- 2.6 Cytokines
- 2.7 Plasma Protein Factor
- 2.8 Recombinant Metabolic Enzymes
- 2.9 Immune Checkpoint Regulators
3 Recombinant Protein Market Overview by Application
- 3.1 Global Recombinant Protein Market Size by Application: 2018 VS 2022 VS 2029
- 3.2 Global Recombinant Protein Historic Market Size by Application (2018-2023)
- 3.3 Global Recombinant Protein Forecasted Market Size by Application (2024-2029)
- 3.4 Biopharmaceutical Companies
- 3.5 Academic and Research Institutes
- 3.6 Contract Research Organizations
4 Recombinant Protein Competition Analysis by Players
- 4.1 Global Recombinant Protein Market Size by Players (2018-2023)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein as of 2022)
- 4.3 Global Key Players of Recombinant Protein Head office and Founded Time
- 4.4 Competitive Status
- 4.5 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
- 5.1 Bio-Techne Corporation
- 5.1.1 Profile
- 5.1.2 Recombinant Proteins Product Overview
- 5.1.3 Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.1.4 Bio-Techne Corporation Recent Developments
- 5.2 Abcam PLC
- 5.2.1 Profile
- 5.2.2 Recombinant Proteins Product Overview
- 5.2.3 Abcam PLC Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.2.4 Abcam PLC Recent Developments
- 5.3 Merck KGaA
- 5.3.1 Profile
- 5.3.2 Recombinant Proteins Product Overview
- 5.3.3 Merck KGaA Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.3.4 Merck KGaA Recent Developments
- 5.4 Miltenyi Biotec
- 5.4.1 Profile
- 5.4.2 Recombinant Proteins Product Overview
- 5.4.3 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.4.4 Miltenyi Biotec Recent Developments
- 5.5 Thermo Fisher Scientific
- 5.5.1 Profile
- 5.5.2 Recombinant Proteins Product Overview
- 5.5.3 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.5.4 Thermo Fisher Scientific Recent Developments
- 5.6 ACROBiosystems
- 5.6.1 Profile
- 5.6.2 Recombinant Proteins Product Overview
- 5.6.3 ACROBiosystems Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.6.4 ACROBiosystems Recent Developments
- 5.7 Sino Biological
- 5.7.1 Profile
- 5.7.2 Recombinant Proteins Product Overview
- 5.7.3 Sino Biological Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.7.4 Sino Biological Recent Developments
- 5.8 Cytiva
- 5.8.1 Profile
- 5.8.2 Recombinant Proteins Product Overview
- 5.8.3 Cytiva Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.8.4 Cytiva Recent Developments
- 5.9 Eurogentec
- 5.9.1 Profile
- 5.9.2 Recombinant Proteins Product Overview
- 5.9.3 Eurogentec Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.9.4 Eurogentec Recent Developments
- 5.10 GenScript Biotech Corporation
- 5.10.1 Profile
- 5.10.2 Recombinant Proteins Product Overview
- 5.10.3 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.10.4 GenScript Biotech Corporation Recent Developments
- 5.11 Reprocell
- 5.11.1 Profile
- 5.11.2 Recombinant Proteins Product Overview
- 5.11.3 Reprocell Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.11.4 Reprocell Recent Developments
- 5.12 BPS Bioscience
- 5.12.1 Profile
- 5.12.2 Recombinant Proteins Product Overview
- 5.12.3 BPS Bioscience Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.13 Abnova Corporation
- 5.13.1 Profile
- 5.13.2 Recombinant Proteins Product Overview
- 5.13.3 Abnova Corporation Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.13.4 Abnova Corporation Recent Developments
- 5.14 ProSpec Tany TechnoGene
- 5.14.1 Profile
- 5.14.2 Recombinant Proteins Product Overview
- 5.14.3 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.15 Ajinomoto
- 5.15.1 Profile
- 5.15.2 Recombinant Proteins Product Overview
- 5.15.3 Ajinomoto Recombinant Proteins Revenue and Gross Margin (2015-2020)
- 5.15.4 Ajinomoto Recent Developments
6 North America
- 6.1 North America Recombinant Protein Market Size by Country (2018-2029)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe
- 7.1 Europe Recombinant Protein Market Size by Country (2018-2029)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic Countries
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Recombinant Protein Market Size by Region (2018-2029)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 South America
- 9.1 South America Recombinant Protein Market Size by Country (2018-2029)
- 9.2 Brazil
- 9.3 Rest of South America
10 Middle East & Africa
- 10.1 Middle East & Africa Recombinant Protein Market Size by Country
- 10.2 GCC Countries
- 10.3 South Africa
- 10.4 Turkey
- 10.5 Rest of Middle East & Africa
11 Recombinant Protein Market Dynamics
- 11.1 Recombinant Protein Industry Trends
- 11.2 Recombinant Protein Market Drivers
- 11.3 Recombinant Protein Market Challenges
- 11.4 Recombinant Proteins Market Growth Strategy
12 Research Finding/Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
- 13.4 Disclaimer